Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» KRAS
KRAS
Roche culls cough candidate, pivots KRAS program after revaluing entire pipeline
Fierce Biotech
Wed, 10/23/24 - 11:29 am
Roche
chronic cough
KRAS
Genentech
Hookipa, reeling from Roche’s KRAS cull, lays off 30% of workforce, deprioritizes programs
Fierce Biotech
Mon, 01/29/24 - 11:24 am
Roche
Hookipa
layoffs
KRAS
Mirati matches Amgen with updated data for KRAS-blocking cancer drug
BioPharma Dive
Fri, 05/27/22 - 10:15 am
Mirati Therapeutics
Amgen
KRAS
adagrasib
Lumakras
clinical trials
Bayer-backed Affini-T snags $175M to enter increasingly crowded KRAS-cancer field
Fierce Biotech
Tue, 03/22/22 - 10:09 am
Affini-T Therapeutics
venture capital
Bayer
KRAS
Merck cuts ties to Moderna's early-phase KRAS vaccine, leaving mRNA specialist to mull next steps
Fierce Biotech
Thu, 02/24/22 - 09:58 am
Merck
Moderna Therapeutics
KRAS
vaccines
mRNA-5671
Seeking an edge over Amgen, Mirati advances lower KRAS dose in Keytruda combo to improve tolerability
Fierce Biotech
Tue, 11/9/21 - 10:49 am
Mirati Therapeutics
Amgen
KRAS
clinical trials
Merck
Keytruda
Boehringer and MD Anderson extend KRAS cancer collaboration
Pharmaforum
Wed, 04/14/21 - 09:39 pm
Boehringer Ingelheim
MD Anderson
KRAS
cancer
Boehringer’s big cancer reveal draws near
EP Vantage
Mon, 03/29/21 - 10:27 am
Boehringer Ingelheim
AACR
cancer
oncology
KRAS
Lilly rejoins KRAS race with swipe at Amgen and Mirati, plans 2021 clinical trial
Fierce Biotech
Thu, 03/11/21 - 10:47 am
Eli Lilly
KRAS
Amgen
Mirati Therapeutics
LY3499446
solid tumors
Amgen plans 2020 filing for FDA approval of KRAS drug sotorasib
Fierce Biotech
Tue, 12/8/20 - 10:43 am
Amgen
FDA
sotorasib
KRAS
Amgen teases 'promising' phase 2 data for closely watched KRAS prospect
Fierce Biotech
Tue, 10/6/20 - 10:26 am
Amgen
clinical trials
non-small cell lung cancer
KRAS
sotorasib
Amgen sees no 'significant delays' from pandemic to novel KRAS cancer drug
Fierce Biotech
Tue, 03/31/20 - 10:54 am
Amgen
KRAS
AMG 510
COVID-19
clinical trials
cancer
Verastem pens KRAS-focused drug licensing deal with Chugai
Fierce Biotech
Wed, 01/8/20 - 10:34 am
Verastem
KRAS
cancer
Chugai
KRAS craze sees Merck put $2.5B biobucks down for Taiho, Astex licensing deal
Fierce Biotech
Mon, 01/6/20 - 10:12 am
Merck
Taiho
Astex
R&D
KRAS
As Amgen zeroes in on cancer, neuroscience pipeline under the ax
Fierce Biotech
Wed, 10/30/19 - 10:20 am
Amgen
KRAS
oncology
cancer
Neuroscience
Novartis sends second wagon after KRAS gold rush
Endpoints
Fri, 10/25/19 - 10:46 am
Novartis
KRAS
drug discovery
Mirati sets date for closely watched clinical KRAS readout
Fierce Biotech
Fri, 10/18/19 - 10:12 am
Mirati Therapeutics
KRAS
MRTX849
Amgen
cancer
As developers work on cracking KRAS, Germany's Boehringer has quietly begun testing its pan-KRAS drug in humans
Endpoints
Wed, 10/2/19 - 07:42 pm
KRAS
cancer
Boehringer Ingelheim
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
Xconomy
Tue, 10/1/19 - 10:29 am
ESMO
PARP inhibitors
prostate cancer
KRAS
Seattle Genetics
AstraZeneca
Merck
GSK
Amgen
breast cancer
Roche
Pfizer
Colon cancer proves tougher target for Amgen's KRAS drug
Biopharma Dive
Sat, 09/28/19 - 04:43 pm
Amgen
colon cancer
ESMO
KRAS
Pages
1
2
next ›
last »